Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) is a manufacturer, designer and marketer of products & systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company has been operating in the healthcare industry since the 60s. The healthcare business has been a separate entity since 2001 when the company split from its appliances business.
The Australia share market retreated to a six-month low on Tuesday, as global markets felt the pressure from surging bond yields – despite, in Australia’s case, the Reserve Bank leaving the official cash rate on hold at 4.1 per cent, for a fifth straight month.
The Fisher & Paykel Healthcare Corporation (ASX:FPH) share price has fallen 6% after revealing a big profit decline in FY23.
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price has gone up around 6% after giving strong FY23 guidance.
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price is up 12% after revealing its HY23 result and outlining some FY23 commentary.
The S&P/ASX 200 (ASX:XJO) gained another 0.5% on Wednesday as Uniti (ASX:UWL) and Fisher & Paykel (ASX:FPH) shares were in the news.
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price has sunk more than 5% after giving investors a trading update.
In part two of our three-part Australian Investors Podcast mini-series on ethical investing in Australia, sponsored by Australian Ethical — a leader in ethical managed funds and superannuation — I’m joined by Mike Murray, CFA.
It was another mixed day for the S&P/ASX 200 (ASX: XJO) on Thursday as EML Payments (ASX:EML) and Kogan (ASX:KGN) shares made headlines.
The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price is up 5% this morning after the company provided its first-half FY22 update.